Cefepime Mylan

Country: New Zealand

Bahasa: Inggeris

Sumber: Medsafe (Medicines Safety Authority)

Bahan aktif:

Cefepime dihydrochloride monohydrate 2.30368 g equivalent to 2 g cefepime free base; Cefepime dihydrochloride monohydrate 2.378 g equivalent to 2 g cefepime free base

Boleh didapati daripada:

Viatris Limited

INN (Nama Antarabangsa):

Cefepime dihydrochloride monohydrate 2.30368 g (equivalent to 2 g cefepime free base)

Dos:

2 g

Borang farmaseutikal:

Powder for injection

Komposisi:

Active: Cefepime dihydrochloride monohydrate 2.30368 g equivalent to 2 g cefepime free base Excipient: Arginine Active: Cefepime dihydrochloride monohydrate 2.378 g equivalent to 2 g cefepime free base Excipient: Arginine

Unit dalam pakej:

Vial, glass, single dose, Type 1 clear glass vial with grey bromo butyl rubber stopper, 2 g

Kelas:

Prescription

Jenis preskripsi:

Prescription

Dikeluarkan oleh:

Fresenius Kabi Anti-Infectives S.r.l.

Tanda-tanda terapeutik:

CEFEPIME Mylan is indicated in adults for the treatment of the infections listed below when caused by susceptible bacteria. · Lower respiratory tract infections, including pneumonia and bronchitis. · Urinary tract infections, both complicated, including pyelonephritis, and uncomplicated infections. · Skin and skin structure infections. · Septicaemia. · Intra-abdominal infections, including peritonitis and biliary tract infections. · Empiric treatment of febrile neutropenia.

Ringkasan produk:

Package - Contents - Shelf Life: Vial, glass, single dose, Type I clear glass vial with grey bromo butyl rubber stopper and flip off aluminium seal - 2 g - 2 years from date of manufacture stored at or below 25°C protect from light 24 hours reconstituted stored at or below 25°C protect from light 168 hours reconstituted stored at 2° to 8°C (Refrigerate, do not freeze) protect from light

Tarikh kebenaran:

2009-06-17